Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis

Background: Kidney transplantation in patients with atypical hemolytic uremic syndrome (aHUS) is frequently complicated by recurrence, resulting in thrombotic microangiopathy in the renal allograft and graft loss. We aimed to assess the use of eculizumab in the prevention and treatment of aHUS recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez Suarez, Maria L., Thongprayoon, Charat, Mao, Michael A., Leeaphorn, Napat, Bathini, Tarun, Cheungpasitporn, Wisit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679118/
https://www.ncbi.nlm.nih.gov/pubmed/31252541
http://dx.doi.org/10.3390/jcm8070919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679118/
https://www.ncbi.nlm.nih.gov/pubmed/31252541
http://dx.doi.org/10.3390/jcm8070919

Ejemplares similares